Mitochondria as targets for cancer therapy
- 2 January 2009
- journal article
- review article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 53 (1) , 9-28
Abstract
Mitochondria have recently emerged as intriguing targets for anticancer drugs. A variety of compounds have been now identified that act via mitochondria. These compounds, termed mitocans (an acronym for mitochondria and cancer), destabilise mitochondria and cause apoptosis, which is, at least in some cases, selective for cancer cells. Mitochondria are the powerhouse of the cell, providing it with energy, as well as the source of important mediators of apoptosis. Recent findings show that individual types of cancers are complex and can differ considerably in their array of DNA mutations, harbouring different sets of genetic causes. This indicates that it will be very unlikely to cure cancer by drugs targeting only a few gene products or single pathways that are essential for tumour survival. What is needed then is an invariant target, common to all cells, but which is predominantly only affected by drugs when delivered inside the cancer cells. Such targets appear to be mitochondria, with very rare mutations, and mitocans can be expected to be very efficient drugs of choice for a number of different types of the neoplastic disease.Keywords
This publication has 185 references indexed in Scilit:
- α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex IIOncogene, 2008
- Targeting HER proteins in cancer therapy and the role of the non-target HER3British Journal of Cancer, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Mitochondria, oxidative stress and cell deathApoptosis, 2007
- Structural and functional analysis of the Na+/H+ exchangerBiochemical Journal, 2007
- The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralizedCancer Cell, 2006
- Localization of superoxide anion production to mitochondrial electron transport chain in 3-NPA-treated cellsMitochondrion, 2006
- Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondriaOncogene, 2006
- Molecular mechanism of ‘mitocan’‐induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl‐2 family proteinsFEBS Letters, 2006
- Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cellsApoptosis, 2005